投資評等
最後更新日期：2024/11/26
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2013/12/11 | FBR Capital | Mkt Perform >> Outperform | $54 >> $62 |
| 2011/11/18 | Caris & Company | Above Average >> Buy | 63 |
| 2011/11/17 | Janney Mntgmy Scott | Neutral >> Buy | |
| 2010/4/27 | JP Morgan | Neutral >> Overweight | |
| 2010/1/27 | MKM Partners | Neutral >> Buy | 39 |
| 2009/10/9 | Stifel Nicolaus | Hold >> Buy | 40 |
| 2009/8/21 | Citigroup | Hold >> Buy | |
| 2009/5/4 | Susquehanna Financial | Neutral Positive | |
| 2006/5/22 | CIBC Wrld Mkts | Sector Underperform Sector Perform | |
| 2005/10/3 | Susquehanna Financial | Neutral->Positive | |
| 2005/3/15 | Lehman Brothers | Underweight->Equal-weight | 48 |
| 2004/5/7 | Roth Capital | Buy->Strong Buy | $33 |
| 2004/2/2 | CSFB | Neutral->Outperform | 32 |
| 2003/7/8 | Brean Murray | Hold -> Buy | 24 |
| 2003/7/8 | Brean Murray | Hold -> Buy | 24 |
| 2003/7/8 | Brean Murray | Hold -> Buy | 24 |
| 2003/6/26 | Lehman Brothers | Equal-weight -> Overweight | 25 |
| 2002/11/15 | Fulcrum | Sell -> Neutral | |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2015/12/7 | Wolfe Research | Outperform >> Peer Perform | |
| 2013/11/21 | Monness Crespi & Hardt | Buy >> Neutral | |
| 2012/10/15 | Caris & Company | Buy >> Above Average | $62 >> $67 |
| 2010/4/29 | Stifel Nicolaus | Buy >> Hold | |
| 2009/5/8 | Citigroup | Buy Hold | |
| 2007/7/30 | Susquehanna Financial | Positive Neutral | |
| 2006/1/4 | Harris Nesbitt | Outperform->Neutral | 58 |
| 2005/5/20 | Susquehanna Financial | Net Positive->Net Neutral | |
| 2004/10/21 | Roth Capital | Strong Buy->Buy | |
| 2004/6/4 | Buckingham Research | Strong Buy->Accumulate | $32 |
| 2002/11/19 | CIBC Wrld Mkts | Secto -> Rerform -> Sector Underperform | |
| 2002/8/1 | Pacific Growth Equities | Equal Weight -> Under Weight | |
| 2002/8/1 | CSFB | Buy -> Hold | 38 |
| 2002/7/31 | Brean Murray | Buy -> Hold | 42 |
| 2002/7/31 | Merrill Lynch | NT Buy/LT Strong Buy -> NT Neutral/LT Neutral | |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2011/4/12 | Barclays Capital | Overweight | 63 |
| 2009/6/10 | Stifel Nicolaus | Hold | 35 |
| 2009/5/6 | Caris & Company | Above Average | |
| 2005/2/15 | Harris Nesbitt | Outperform | 49 |
| 2004/10/28 | Lehman Brothers | Underweight | 28 |
| 2004/9/15 | JP Morgan | Neutral | |
| 2004/5/26 | Ryan, Beck & Co | Outperform | 32 |
| 2004/4/21 | Roth Capital | Buy | 35 |
| 2002/8/21 | Goldman Sachs | Mkt Perform | |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 2003/10/9 | Wells Fargo Sec | Buy | 28 |
| 2002/9/30 | Fulcrum | Sell | 6 |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2012/10/12 | FBR Capital | Mkt Perform | $55 >> $60 |
| 2012/3/8 | Janney Mntgmy Scott | Buy | $60 >> $58 |
| 2011/4/26 | Wedbush | Outperform | $53 >> $57 |
| 2010/11/18 | Wedbush | Outperform | $50 >> $53 |
| 2010/10/21 | Wedbush | Outperform | $52 >> $50 |
| 2010/5/21 | Caris & Company | Above Average | $57 >> $60 |
| 2010/5/20 | Wedbush | Outperform | $50 >> $53 |
| 2010/4/27 | Caris & Company | Above Average | $48 >> $57 |
| 2010/3/15 | Caris & Company | Above Average | $41 >> $48 |
| 2010/2/5 | Caris & Company | Above Average | $39 >> $41 |